About: MorphoSys

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: MorphoSys Goto Sponge NotDistinct Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMorphoSys&invfp=IFP_OFF&sas=SAME_AS_OFF

MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise yago:WikicatBiotechnologyCompanies yago:WikicatBiotechnologyCompaniesOfGermany yago:WikicatCompaniesBasedInBavaria yago:WikicatCompaniesEstablishedIn1992 yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity organisation yago:SocialGroup107950920
rdfs:label	Morphosys (de) MorphoSys (fr) MorphoSys (en)
rdfs:comment	Die Morphosys AG (Eigenschreibweise MorphoSys) ist ein 1992 gegründetes biopharmazeutisches Unternehmen mit Sitz in Planegg in der Nähe von München. Das Unternehmen verfügt über verschiedene Antikörper-, Protein- und Peptid-Technologien, die es zur Erforschung und Entwicklung sowohl eigener als auch verpartnerter Arzneimittelkandidaten einsetzt. Morphosys hat nach eigenen Angaben mehr als 100 Medikamente in seiner Pipeline, die für die Behandlung einer Vielzahl von Krankheiten untersucht werden. Während viele davon in Partnerschaften mit Pharma- und Biotech-Unternehmen entwickelt werden, verfügt Morphosys auch über eine firmeneigene Pipeline mit dem Schwerpunkt Krebs. Zur Gesellschaft gehört eine hundertprozentige Tochtergesellschaft in Boston im US-Bundesstaat Massachusetts. (de) MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company has more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases. While many of these are being developed in partnership with pharma and biotech companies, MorphoSys also has a proprietary pipeline with a focus on cancer and autoimmune diseases. (en) MorphoSys est une société biopharmaceutique fondée en 1992. Son siège est situé près de Munich, en Allemagne, et elle détient une filiale à 100 %, MorphoSys US Inc., à Boston (Massachusetts, États-Unis), où elle met actuellement en place une entité commerciale. La société dispose de diverses technologies d’anticorps, de protéines et de peptides, qu’elle utilise pour découvrir et développer ses propres candidat-médicaments, mais aussi des candidats-médicaments dans le cadre de partenariats. Dans son pipeline de développement, la société affirme détenir pas moins de 100 candidat-médicaments sous étude couvrant une grande variété de maladies. Si un grand nombre d’entre eux sont développés en partenariat avec des entreprises pharmaceutiques et biotechnologiques, MorphoSys dispose également d’u (fr)
foaf:name	MorphoSys AG (en)
foaf:homepage	http://www.morphosys.com/
name	MorphoSys AG (en)
foaf:depiction
dcterms:subject	1992 establishments in Germany Companies in the TecDAX Companies in the MDAX Biotechnology companies established in 1992 Biotechnology companies of Germany
Wikipage page ID	22119388 (xsd:integer)
Wikipage revision ID	1095233413 (xsd:integer)
Link from a Wikipage to another Wikipage	Cancer Prescription Drug User Fee Act MDAX Bayer Boston 1992 establishments in Germany Hoffmann-La Roche Johnson & Johnson Peptide Pfizer Rheumatoid arthritis Companies in the TecDAX Frankfurt Stock Exchange Germany GlaxoSmithKline Greater China Munich Antibody Lenalidomide MOR103 Clinical trial Chief Commercial Officer Chief Financial Officer Janssen Biotech American depositary shares Novartis Phage display Protein Guselkumab Companies in the MDAX Biotechnology companies established in 1992 Chief Executive Officer Biopharmaceutical Biotechnology Tafasitamab Diffuse large B-cell lymphoma Autoimmune disease Biotechnology companies of Germany CD19 CD38 Planegg Plaque psoriasis Public Company Immunotherapy Incyte Initial public offering Nasdaq Autoimmune diseases Autologous stem cell transplant Membranous nephropathy Schering AG Tremfya B-cell malignancies Supervisory Board GM-CSF Marketing approval Biologics License Application
Link from a Wikipage to an external page	http://www.i-mabbiopharma.com/en/ http://www.morphosys.com/ https://www.lanthiopharma.com/

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 55 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software